Changes in chemotherapy usage and outcome of early breast cancer patients in the last decade

BACKGROUND: During the last decade, neoadjuvant chemotherapy (NACT) of early breast cancer (EBC) evolved from a therapy intended to enable operability to a standard treatment option aiming for increasing cure rates equivalent to adjuvant chemotherapy (ACT). In parallel, improvements in the quality c...

Descripción completa

Detalles Bibliográficos
Autores principales: Hennigs, A., Riedel, F., Marmé, F., Sinn, P., Lindel, K., Gondos, A., Smetanay, K., Golatta, M., Sohn, C., Schuetz, F., Heil, J., Schneeweiss, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5090013/
https://www.ncbi.nlm.nih.gov/pubmed/27744486
http://dx.doi.org/10.1007/s10549-016-4016-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5090013/
https://www.ncbi.nlm.nih.gov/pubmed/27744486
http://dx.doi.org/10.1007/s10549-016-4016-4

Ejemplares similares